Franklin Resources' aggressive focus on Alternative Assets has failed to deliver management fee margin expansion, raising ...

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products ...